These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2293558)

  • 1. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
    Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
    Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.
    Olumi AF; Tsai YC; Nichols PW; Skinner DG; Cain DR; Bender LI; Jones PA
    Cancer Res; 1990 Nov; 50(21):7081-3. PubMed ID: 2208176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelotype of human bladder cancer.
    Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
    Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
    Erbersdobler A; Friedrich MG; Schwaibold H; Henke RP; Huland H
    Oncol Res; 1998; 10(8):415-20. PubMed ID: 10100758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
    Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of chromosome 9 in human bladder cancer.
    Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
    Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
    Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
    Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.
    Orlow I; Lianes P; Lacombe L; Dalbagni G; Reuter VE; Cordon-Cardo C
    Cancer Res; 1994 Jun; 54(11):2848-51. PubMed ID: 8187066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer.
    Simon R; Bürger H; Brinkschmidt C; Böcker W; Hertle L; Terpe HJ
    J Pathol; 1998 Aug; 185(4):345-51. PubMed ID: 9828832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulated allelic losses in the development of invasive urothelial cancer.
    Habuchi T; Ogawa O; Kakehi Y; Ogura K; Koshiba M; Hamazaki S; Takahashi R; Sugiyama T; Yoshida O
    Int J Cancer; 1993 Feb; 53(4):579-84. PubMed ID: 8094713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
    Matsumura K; Kallioniemi A; Kallioniemi O; Chen L; Smith HS; Pinkel D; Gray J; Waldman FM
    Cancer Res; 1992 Jun; 52(12):3474-7. PubMed ID: 1350754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic changes associated with ovarian cancer.
    Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
    Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
    Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
    Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allelic losses on chromosomes 1p, 3p, 11p, 11q in non small cell lung cancers].
    Cheng JQ; Crépin M; Hamelin R
    C R Acad Sci III; 1990; 311(5):175-9. PubMed ID: 2169974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
    Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC
    Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
    Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
    Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
    van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
    Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.
    Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y
    Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial allelotype of carcinoma in situ of the human bladder.
    Rosin MP; Cairns P; Epstein JI; Schoenberg MP; Sidransky D
    Cancer Res; 1995 Nov; 55(22):5213-6. PubMed ID: 7585577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.